These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27914986)

  • 1. Identification of epigenetically downregulated Tmem70 and Ube2e2 in rat liver after 28-day treatment with hepatocarcinogenic thioacetamide showing gene product downregulation in hepatocellular preneoplastic and neoplastic lesions produced by tumor promotion.
    Mizukami S; Yafune A; Watanabe Y; Nakajima K; Jin M; Yoshida T; Shibutani M
    Toxicol Lett; 2017 Jan; 266():13-22. PubMed ID: 27914986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
    Abe H; Ogawa T; Wang L; Kimura M; Tanaka T; Morita R; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):467-74. PubMed ID: 25151969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of UBE2E2 in rat liver cells after hepatocarcinogen treatment facilitates cell proliferation and slowing down of DNA damage response in GST-P-expressing preneoplastic lesions.
    Mizukami S; Watanabe Y; Saegusa Y; Nakajima K; Ito Y; Masubuchi Y; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2017 Nov; 334():207-216. PubMed ID: 28899750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of TMEM70 in Rat Liver Cells After Hepatocarcinogen Treatment Related to the Warburg Effect in Hepatocarcinogenesis Producing GST-P-Expressing Proliferative Lesions.
    Mizukami S; Watanabe Y; Nakajima K; Hasegawa-Baba Y; Jin M; Yoshida T; Shibutani M
    Toxicol Sci; 2017 Sep; 159(1):211-223. PubMed ID: 28903497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Characteristics of Genes Hypermethylated and Downregulated in Rat Liver Specific to Nongenotoxic Hepatocarcinogens.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    Toxicol Sci; 2019 May; 169(1):122-136. PubMed ID: 30690589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of low-density lipoprotein receptor class A domain-containing protein 4 (Ldlrad4) in the liver of rats treated with nongenotoxic hepatocarcinogen to induce transforming growth factor β signaling promoting cell proliferation and suppressing apoptosis in early hepatocarcinogenesis.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Okano H; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    J Appl Toxicol; 2020 Nov; 40(11):1467-1479. PubMed ID: 32596862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
    Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
    Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of GST-P-positive proliferative lesions facilitating lipid peroxidation with possible involvement of transferrin receptor up-regulation and ceruloplasmin down-regulation from the early stage of liver tumor promotion in rats.
    Mizukami S; Ichimura R; Kemmochi S; Taniai E; Shimamoto K; Ohishi T; Takahashi M; Mitsumori K; Shibutani M
    Arch Toxicol; 2010 Apr; 84(4):319-31. PubMed ID: 20091025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of cell cycle proteins in the livers of rats treated with hepatocarcinogens for 28 days.
    Yafune A; Taniai E; Morita R; Nakane F; Suzuki K; Mitsumori K; Shibutani M
    Arch Toxicol; 2013 Jun; 87(6):1141-53. PubMed ID: 23411599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global DNA methylation screening of liver in piperonyl butoxide-treated mice in a two-stage hepatocarcinogenesis model.
    Yafune A; Kawai M; Itahashi M; Kimura M; Nakane F; Mitsumori K; Shibutani M
    Toxicol Lett; 2013 Oct; 222(3):295-302. PubMed ID: 23968726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model.
    Ichimura R; Mizukami S; Takahashi M; Taniai E; Kemmochi S; Mitsumori K; Shibutani M
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):128-40. PubMed ID: 20423715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats.
    Omura K; Uehara T; Morikawa Y; Hayashi H; Mitsumori K; Minami K; Kanki M; Yamada H; Ono A; Urushidani T
    J Toxicol Sci; 2014; 39(5):785-94. PubMed ID: 25242409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Taniai E; Kawai M; Dewa Y; Nishimura J; Harada T; Saegusa Y; Matsumoto S; Takahashi M; Mitsumori K; Shibutani M
    Cancer Sci; 2009 May; 100(5):813-20. PubMed ID: 19309364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice.
    Roomi MW; Gaal K; Yuan QX; French BA; Fu P; Bardag-Gorce F; French SW
    Exp Mol Pathol; 2006 Aug; 81(1):8-14. PubMed ID: 16729998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
    Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
    World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of DNA methylation and gene expression of rat liver in a 2-stage hepatocarcinogenesis model.
    Omura K; Uehara T; Morikawa Y; Hayashi H; Mitsumori K; Minami K; Kanki M; Yamada H; Ono A; Urushidani T
    J Toxicol Sci; 2014; 39(6):837-48. PubMed ID: 25374375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.